The expanding field of biological therapy relies heavily on recombinant cytokine technology, and a thorough understanding of individual profiles is absolutely crucial for refining experimental design and therapeutic efficacy. Specifically, examining the properties of recombinant IL-1A, IL-1B, IL-2, and IL-3 demonstrates important differences in the